Drug information provided by: Merative, Micromedex®
Pemigatinib is used to treat cholangiocarcinoma (bile duct cancer) that has spread or cannot be removed by surgery in patients who have already tried cancer treatment before and have a certain type of abnormal FGFR2 gene in their cancer. Your doctor will test for the presence of this gene.
Pemigatinib is also used to treat myeloid/lymphoid neoplasms (blood cancer) that has come back or did not respond to treatment in patients who have a certain type of abnormal FGFR1 gene in their cancer. Your doctor will test for the presence of this gene.
Pemigatinib is an antineoplastic (cancer) agent. It interferes with the growth of cancer cells, which are eventually destroyed by the body.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Sept. 01, 2023
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
A generous benefactor has pledged $1 million and challenged us to raise an additional $250,000. Help us reach our goal!